FdaApplication
BLA 208751
Identifiers
- fda_app_no: BLA208751
Properties
| Property | Value |
|---|---|
| applicant_name | Novo Nordisk Inc. |
| application_type | BLA |
| approval_date | 2017-09-29 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FIASP | INSULIN ASPART | 1000UNITS/10ML (100UNITS/ML) | Injection |
| FIASP | INSULIN ASPART | 300UNITS/3ML (100UNITS/ML) | Injection |
| FIASP | INSULIN ASPART | 300UNITS/3ML (100UNITS/ML) | Injection |
| FIASP | — | 160UNITS/1.6ML (100UNITS/ML) | Injection |
4 products